CDP-choline modulates matrix metalloproteinases in rat sciatic injury

Area of Science:

• Neuroscience
• Biochemistry
• Regenerative Medicine

Background:

• Cytidine-5'-diphosphocholine (CDP-choline) is known to improve functional recovery and nerve regeneration in peripheral nerve injuries.
• Its precise mechanism, particularly concerning matrix metalloproteinase (MMP) activity, in sciatic nerve injury models requires further elucidation.

Purpose of the Study:

• To investigate the mechanism of action of CDP-choline in modulating matrix metalloproteinase (MMP) activity following sciatic nerve transection in rats.
• To assess the impact of CDP-choline on MMPs, their inhibitors (TIMPs), and axonal regeneration.

Main Methods:

• Male Wistar rats were divided into Sham, Saline, and CDP-choline treatment groups.
• Sciatic nerve transection was performed, followed by intraperitoneal administration of Saline or CDP-choline.
• Nerve samples were analyzed for MMP-2, MMP-9, TIMP-1, TIMP-3 levels/activities, and axonal regeneration at 1, 3, and 7 days post-injury.

Main Results:

• CDP-choline significantly decreased MMP-2 and MMP-9 levels and activities on days 3 and 7 post-injury compared to the Saline group.
• CDP-choline treatment increased TIMP-1 and TIMP-3 levels on days 3 and 7 post-injury.
• Administration of CDP-choline promoted new axon formation and myelination, indicating enhanced nerve regrowth.

Conclusions:

• CDP-choline modulates MMP activity and upregulates TIMP expression, thereby stimulating axonal regeneration.
• These findings provide mechanistic insights into the neuroprotective effects of CDP-choline in peripheral nerve injury models.